Fig. 1From: Heterogeneous response and progression patterns reveal phenotypic heterogeneity of tyrosine kinase inhibitor response in metastatic renal cell carcinomaFlowchart of patient selection for radiological heterogeneity analysis. PD progressive diseaseBack to article page